Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 16 | 2021 | 336 | 5.270 |
Why?
|
| Papillomavirus Vaccines | 8 | 2021 | 151 | 3.540 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2022 | 864 | 3.010 |
Why?
|
| Puerto Rico | 30 | 2023 | 1378 | 2.650 |
Why?
|
| HIV Infections | 15 | 2023 | 2303 | 2.090 |
Why?
|
| Anus Neoplasms | 5 | 2017 | 49 | 2.010 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2023 | 121 | 1.980 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 215 | 1.440 |
Why?
|
| Parents | 4 | 2021 | 329 | 1.400 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2021 | 404 | 1.370 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2014 | 164 | 1.230 |
Why?
|
| Sexual Behavior | 6 | 2017 | 609 | 1.210 |
Why?
|
| Heroin Dependence | 4 | 2011 | 23 | 1.190 |
Why?
|
| Adult | 31 | 2017 | 11712 | 1.180 |
Why?
|
| Young Adult | 20 | 2017 | 4268 | 1.170 |
Why?
|
| Hepatitis C | 2 | 2023 | 125 | 1.040 |
Why?
|
| Male | 33 | 2022 | 20025 | 1.000 |
Why?
|
| Middle Aged | 25 | 2017 | 10129 | 1.000 |
Why?
|
| Humans | 41 | 2023 | 37093 | 0.910 |
Why?
|
| Adolescent | 17 | 2017 | 5363 | 0.900 |
Why?
|
| Vegetables | 2 | 2014 | 147 | 0.870 |
Why?
|
| Drug Users | 1 | 2023 | 46 | 0.860 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2017 | 277 | 0.850 |
Why?
|
| Fruit | 2 | 2014 | 173 | 0.850 |
Why?
|
| Risk Factors | 11 | 2023 | 3562 | 0.750 |
Why?
|
| Homosexuality, Male | 3 | 2017 | 458 | 0.730 |
Why?
|
| Female | 22 | 2022 | 20969 | 0.730 |
Why?
|
| Mass Screening | 3 | 2022 | 462 | 0.730 |
Why?
|
| Neoplasms | 3 | 2016 | 1103 | 0.690 |
Why?
|
| Alphapapillomavirus | 3 | 2014 | 38 | 0.690 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 336 | 0.690 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 2721 | 0.670 |
Why?
|
| Prevalence | 7 | 2023 | 1455 | 0.590 |
Why?
|
| Sex | 1 | 2016 | 3 | 0.580 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 441 | 0.560 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 59 | 0.560 |
Why?
|
| Communication | 2 | 2016 | 180 | 0.550 |
Why?
|
| Risk-Taking | 5 | 2023 | 451 | 0.550 |
Why?
|
| Penile Diseases | 1 | 2015 | 7 | 0.530 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 187 | 0.530 |
Why?
|
| Harm Reduction | 2 | 2011 | 21 | 0.490 |
Why?
|
| Consumer Health Information | 1 | 2014 | 22 | 0.490 |
Why?
|
| Papillomaviridae | 1 | 2015 | 127 | 0.480 |
Why?
|
| Mouth Diseases | 1 | 2014 | 6 | 0.480 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 26 | 0.470 |
Why?
|
| Health Personnel | 1 | 2016 | 228 | 0.470 |
Why?
|
| Gastroenterology | 1 | 2013 | 7 | 0.470 |
Why?
|
| Medical Oncology | 1 | 2013 | 30 | 0.460 |
Why?
|
| Anal Canal | 1 | 2014 | 30 | 0.460 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 1067 | 0.460 |
Why?
|
| Incidence | 6 | 2017 | 922 | 0.450 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 137 | 0.450 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 128 | 0.450 |
Why?
|
| Syphilis | 1 | 2013 | 23 | 0.440 |
Why?
|
| Penile Neoplasms | 1 | 2012 | 14 | 0.430 |
Why?
|
| Education, Medical | 1 | 2013 | 104 | 0.420 |
Why?
|
| Attitude to Health | 1 | 2015 | 325 | 0.410 |
Why?
|
| Heroin | 1 | 2011 | 13 | 0.410 |
Why?
|
| Unsafe Sex | 2 | 2012 | 161 | 0.400 |
Why?
|
| Seroepidemiologic Studies | 3 | 2023 | 68 | 0.380 |
Why?
|
| Child | 4 | 2021 | 3131 | 0.370 |
Why?
|
| Health Status Disparities | 1 | 2017 | 642 | 0.370 |
Why?
|
| Promethazine | 1 | 2010 | 2 | 0.370 |
Why?
|
| Self Medication | 1 | 2010 | 13 | 0.360 |
Why?
|
| United States | 6 | 2021 | 4223 | 0.350 |
Why?
|
| Hepatitis C, Chronic | 1 | 2010 | 39 | 0.350 |
Why?
|
| Time Factors | 5 | 2017 | 1742 | 0.340 |
Why?
|
| Feeding Behavior | 1 | 2013 | 454 | 0.340 |
Why?
|
| Age Factors | 4 | 2017 | 1033 | 0.340 |
Why?
|
| Schools | 2 | 2021 | 260 | 0.340 |
Why?
|
| Health Behavior | 1 | 2013 | 537 | 0.340 |
Why?
|
| Vaccination | 2 | 2021 | 288 | 0.340 |
Why?
|
| Sexual Partners | 4 | 2017 | 314 | 0.330 |
Why?
|
| Genotype | 4 | 2015 | 730 | 0.330 |
Why?
|
| Aged | 8 | 2014 | 6741 | 0.320 |
Why?
|
| Emigration and Immigration | 1 | 2008 | 82 | 0.320 |
Why?
|
| Diet | 1 | 2014 | 801 | 0.310 |
Why?
|
| Age Distribution | 4 | 2014 | 225 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1502 | 0.280 |
Why?
|
| Vietnam | 3 | 2011 | 50 | 0.280 |
Why?
|
| Health Promotion | 1 | 2010 | 653 | 0.240 |
Why?
|
| Capacity Building | 2 | 2017 | 87 | 0.240 |
Why?
|
| Focus Groups | 2 | 2016 | 348 | 0.240 |
Why?
|
| Comorbidity | 2 | 2017 | 623 | 0.230 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 730 | 0.230 |
Why?
|
| Registries | 3 | 2014 | 335 | 0.230 |
Why?
|
| Hepacivirus | 1 | 2023 | 62 | 0.220 |
Why?
|
| Sex Factors | 2 | 2017 | 898 | 0.210 |
Why?
|
| Cost of Illness | 2 | 2014 | 76 | 0.210 |
Why?
|
| Smoking | 3 | 2014 | 940 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 664 | 0.200 |
Why?
|
| Sex Distribution | 3 | 2014 | 215 | 0.200 |
Why?
|
| Colonoscopy | 1 | 2022 | 104 | 0.200 |
Why?
|
| Internet | 1 | 2021 | 211 | 0.170 |
Why?
|
| Poisson Distribution | 1 | 2017 | 38 | 0.150 |
Why?
|
| Sexual Abstinence | 1 | 2016 | 8 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 191 | 0.140 |
Why?
|
| Sex Education | 1 | 2016 | 30 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2011 | 400 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2017 | 212 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 215 | 0.130 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 219 | 0.130 |
Why?
|
| Dominican Republic | 1 | 2015 | 20 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2017 | 238 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2017 | 753 | 0.120 |
Why?
|
| HIV Seroprevalence | 1 | 2014 | 14 | 0.120 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 21 | 0.120 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 35 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 32 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 54 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 275 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2013 | 84 | 0.110 |
Why?
|
| Survival Rate | 1 | 2014 | 311 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2013 | 86 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 275 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 217 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2014 | 325 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2013 | 149 | 0.110 |
Why?
|
| Morbidity | 1 | 2013 | 91 | 0.110 |
Why?
|
| Health Facilities | 1 | 2013 | 27 | 0.110 |
Why?
|
| Data Collection | 1 | 2013 | 194 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2014 | 381 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 49 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 373 | 0.110 |
Why?
|
| Trust | 1 | 2014 | 133 | 0.110 |
Why?
|
| Risk | 1 | 2013 | 267 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 178 | 0.110 |
Why?
|
| Culture | 1 | 2013 | 173 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 923 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 61 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2013 | 125 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 251 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 62 | 0.100 |
Why?
|
| Students, Medical | 1 | 2013 | 130 | 0.100 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 140 | 0.100 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 80 | 0.100 |
Why?
|
| Age of Onset | 1 | 2011 | 100 | 0.100 |
Why?
|
| Prognosis | 1 | 2014 | 739 | 0.100 |
Why?
|
| Physicians | 1 | 2013 | 163 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 974 | 0.100 |
Why?
|
| Patient Selection | 1 | 2012 | 164 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 204 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 63 | 0.090 |
Why?
|
| Health Status | 1 | 2014 | 380 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 661 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2379 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 147 | 0.090 |
Why?
|
| Quality of Life | 1 | 2014 | 481 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 560 | 0.090 |
Why?
|
| Disease Progression | 1 | 2011 | 601 | 0.080 |
Why?
|
| Depression | 1 | 2014 | 712 | 0.080 |
Why?
|
| Minority Groups | 1 | 2012 | 596 | 0.070 |
Why?
|
| Acculturation | 1 | 2008 | 188 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2008 | 189 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2010 | 1378 | 0.070 |
Why?
|
| Body Piercing | 1 | 2005 | 2 | 0.070 |
Why?
|
| Tattooing | 1 | 2005 | 7 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1067 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2005 | 27 | 0.060 |
Why?
|
| HIV-1 | 1 | 2011 | 706 | 0.060 |
Why?
|
| Health Occupations | 1 | 2005 | 17 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 85 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2008 | 1492 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 935 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 104 | 0.030 |
Why?
|
| New York City | 1 | 2011 | 220 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 201 | 0.020 |
Why?
|